FDA Warning Letter — Exxon

Case 534802 — FEI 3013692249

The FDA took a Warning Letter action against Exxon on Aug 10, 2017 (Fountain Inn, SC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon
Date
Aug 10, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Fountain Inn, SC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.